These studies had also shown that PDE-5 inhibitors could be safely used in Child's A and B cirrhosis, and they might be considered as a treatment option for CLDs patients (89, 90), but these studies had not documented the efficacy in patients with cirrhosis. Here, PDE5A is linked to Cirrhosis.